Sulfotransferase inhibitors
a technology of sulfotransferase and inhibitor, which is applied in the direction of biocide, drug composition, immunological disorders, etc., can solve the problem that their possibility of being used as therapeutic agents is extremely low
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 1
Preparation of the Substances of the Present Invention:
[0054] (1) Preparation of Substance 1 of the Present Invention
[0055] In 1.5 cm3 of dry pyridine, 21.7 mg (0.073 mmol) of phenyl 2-acetamide-2-deoxy-α-D-galactopyranoside (Compound 1) was dissolved, and 20.1 mg (0.126 mmol) of sulfur trioxide-pyridine complex was added thereto, followed by stirring at room temperature for 6 hours. To the reaction mixture, 1.5 cm3 of methanol was added, and the mixture was passed through a column of Na+ type ion exchange resin (PARTISIL10SAX, manufactured by Whatman), and the eluate was concentrated under reduced pressure to obtain 34.4 mg of Compound 2 (Substance 1 of the present invention). Compound 2 was purified by high performance liquid chromatography (HPLC) using a column of ion exchange resin (PARTISIL10SAX, manufactured by Whatman) and by gel filtration (using a Superdex 30 column, manufactured by Pharmacia Biotech). Substance 1 of the present invention prepared in this manner was ana...
example 2
[0073] The enzyme activity was measured by modifying the method described in J. Biol. Chem., 276, 43894-43900 (2001). As the standard reaction solution, 2.5 μmol of imidazole-HCl (pH 6.8), 0.5 μmol of CaCl2, 1 μmol of reduced type glutathione, 25 nmol in galactosamine equivalent of chondroitin sulfate A (derived from whale cartilage, manufactured by Seikagaku Corporation), 50 pmol of [35S]PAPS (active sulfate: about 5.0×105 cpm: prepared according to Anal. Biochem., 148, 303-310 (1985)), and human-derived GalNAc4S6ST prepared according to the method described in J. Biol. Chem., 276, 43894-43900 (2001) were added to 50 μl. The reaction was started by adding each of Substance 1 of the present invention, Substance 2 of the present invention, Substance 3 of the present invention, Substance 4 of the present invention, Substance 5 of the present invention and Substance 6 of the present invention to this reaction system to give a final concentration of 50 nmol, 125 nmol or 250 nmol.
[0074]...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com